Additional file 1 of Impact of diagnosis to ablation time on clinical outcomes in patients with atrial fibrillation: post hoc analysis of the CABANA trial

Additional file 1: Table S1. Proportions of patients with previous or current use of specific antiarrhythmic drugs at baseline. Table S2. Baseline characteristics for patients randomised to ablation and drug arms. Table S3. Kaplan–Meier estimates of cumulative incidence of the primary outcome at different timepoints during the follow-up. Figure S1. Effects of different ablation timing on post-ablation outcomes based on multivariable Cox regression models among patients randomised to ablation arm. Figure S2. Effects of different ablation timing on post-ablation outcomes based on multivariable Cox regression models. Figure S3. Kaplan–Meier estimates of the cumulative incidence of the primary outcome.